NICE Green Lights Pixantrone in UK

The independent body responsible for driving improvement and excellence in the health and social care system in the United Kingdom has given the green light for pixantrone as a treatment for some B-cell non-Hodgkin's lymphomas.

The National Institute for Health and Care Excellence (NICE), which "develops guidance, standards and information on high-quality health and social care" in the UK, has given the green light in final draft guidance for Cell Therapeutics' pixantrone (Pixuvri) following the lead set by the European Commission.

Stipulations of the recommendation

According to NICE, the drug should be funded by the National Health Services (NHS) to treat certain people with aggressive non-Hodgkin's B-cell lymphoma.

However, the recommendation comes with a few caveats:

  • - Patients must have relapsed or refractory disease.
  • - Patients must have received rituximab as treatment previously.
  • - This must be in the third or fourth line setting.

According to the recommendation, pixantrone is being made available for funding on the condition that Cell Therapeutics provides it at a discounted rate.

Why pixantrone has not been FDA-approved

The U.S. Food and Drug Administration has not approved pixantrone for the U.S. market – and currently shows no signs of doing so, largely due to incomplete and unimpressive clinical trial data.

Source: NICE

More Articles

More Articles

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...

Secondary cancers are cancers that develop as a result of chemotherapy and/or...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...

Over the years, various classification systems have been used to differentiate lymphoma types including the Rappaport Classification (used until...

If you are new to this website or are looking for guidance to a specific page, here is a list of links to articles that can help you. The "Main...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...